Learn a little about the history of our suppliers and their products
BioNovus Life Sciences is proud to represent the companies listed on this website. Each of our suppliers is a company which is dedicated to supplying the highest quality products and to serving the needs of their customers. We believe our suppliers each provide products which offer our customers value for money, the highest quality and excellent performance.
In addition to being the Australian distributor for each of our suppliers, we also can supply customers in New Zealand with products from Crosstex Industrial.
4BioDx is the brand name of the sales and marketing company formed by SPQI (Services and Products of Quality and Innovative) which develops, produces and commercialises laboratory reagents for research (monoclonal antibodies, polyclonal antibodies and ELISA kits). Based in Lille (North of France), the company SPQI is a spin-off of prestigious research institutes namely Institut National de la Santé et de la Recherche Médicale headed by Pr. Luc Buée, CNRS (“Centre National de la Recherche scientifique”), University of Lille and Lille Hospital in North of France.
Neurodegenerative Biomarkers: 4BioDx has a range of monoclonal and polyclonal antibodies specific for several tau proteins and APP (amyloid protein precursors), which are important biomarkers in the investigation of the underlying processes of neurodegenerative diseases.
Male Infertility: 4BioDx have a range of ELISA kits, monoclonal and polyclonal antibodies for the investigation of male infertility, specifically targeting proAKAP4 (A-kinase anchor protein 4), an important biomarker of sperm motility.
ChromoTek GmbH are pioneers a new class of immunologic research tools derived from single domain camel antibodies for cell biology and proteomics. Founded in 2008 as a spin-off from the Ludwig-Maximilians University Munich (LMU) by a research team lead by Ulrich Rothbauer, ChromoTek has rapidly developed to become a highly regarded supplier of innovative reagents.
Next to conventional antibodies, alpaca also possess single domain antibodies (sdAbs). In contrast to conventional mammalian IgG antibodies, sdAbs contain only heavy chains and are devoid of light chains. The antigen binding domain of a single domain antibody is called VHH or Nanobody. VHHs have several general advantages; ChromoTek’s Nanobodies and Nanobody-based research tools, however, have even more advantages: their high level of performance, characterization, and validation.
This single domain contains a complete antigen binding site and is the smallest functional antigen binding fragment (around 15 kDa, only one tenth the size of a conventional antibody).
Origin of Nanobodies and comparison with conventional antibodies
For more than a decade, ChromoTek has generated highly specific and high affinity VHH antibodies for various applications. By combining their proprietary immunization scheme with phage display, ChromoTek are able to create recombinant sdAbs with tailor-made properties. Using this technique, they get the best of both worlds: Highly specific antibodies that have undergone affinity maturation in vivo, but that are produced recombinantly with known sequences and without any batch-to-batch variations. Typically, affinities are in the picomolar to single-digit nanomolar range. Subsequently, the VHH domains can be further engineered or adapted, depending on the requirements of an application.
Creative Biomart is a supplier of high quality recombinant proteins, antibodies, antigens, enzymes and ELISA assays to the researchers in biology, clinical research, molecular diagnostics and biopharmaceutical drug development and related fields.
Creative Biomart have available 1,000’s of recombinant proteins, peptides and antibodies. All their products are rigorously tested to meet the most demanding research needs.
|Research areas covered by the Creative Biomart products:|
Innova Biosciences was formed in 2002 and the revolutionary Lightning-Link® range of antibody labelling system was launched in 2006 as a direct response to the problems associated with other antibody labelling systems. Innova Biosciences’ product portfolio continued to expand to beyond the Lightning-Link® protein and antibody conjugation product to include additional innovative product products such InnovaCoat® and Thunder-Link®. Research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide have benefited from these and related products. In mid 2017 Sygnis AG acquired Innova Biosciences and their unique range of bioconjugation products which are now available under the Expedeon brand name.
Protein and Antibody Conjugation
Expedeon’s range of innovative, quick and reliable conjugation systems enable researchers to confidently label the protein or antibody of interest with a variety of labels and chemistries for use in downstream applications.
Choose from Expedeon’s range of kits that facilitate simple and stable conjugation to labels that include enzymes, haptens, oligonucleotides and nano-particles.
Jellagen is an innovative marine biotechnology company was co-founded in 2013 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer. The idea first came to Andrew whilst surfing off the East coast of Scotland in his youth swimming through blooms of jellyfish.
For many decades, collagen extracted from mammalian (pigs, cows, sheep) have been successfully used in the food, cosmetic, medical device and pharmaceutical industries. However due to rising safety concerns around use of mammalian derived products (viral disease vectors and BSE), safer alternatives are being sought. Jellyfish offer that safer and disease-free alternative.
In 2018, Jellagen successfully commercialised its jellyfish collagen cell culture products for research and subsequently achieved ISO13485 certification for their collagen manufacturing processes.
Innovative collagen sourced from jellyfish
Jellyfish collagen is an evolutionary ancient chemical template and is where all collagens up the tree of life have been derived. Jellyfish collagen is in essence, the root of all collagens, compatible with a broad range of cell types making it an ideal biomaterial for medical devices.
Jellagen produces research grade functional non-mammalian collagen products sustainably sourced from jellyfish (Rhizostoma pulmo). Fibrillar collagens such as type I, II, III and V exist as a triple helix. These form strong fibers that can be made into structures with excellent biocompatability, making collagen a highly versatile biomaterial. Jellagen’s non-mammalian collagen retains its triple helix structure producing a functional collagen. As an alternative to mammalian collagen, Jellagen jellyfish collagen has similar proliferation characteristics, induces the same morphology in cells and is not cytotoxic.
Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Their portfolio of reagents continues to expand rapidly, and they are now widely acknowledged to be a primary source of reagents and kits for studying emerging diseases.
The Native Antigen Company specialises in the production of bacterial, protozoan and viral antigens and antibodies and related products. Their scientific know-how focuses on the isolation and purification of native antigens and the use of high-yielding mammalian cell expression systems which ensure conformity to native type.
Oxford Biomedical Research was founded in 1984 by Denis M. Callewaert Ph.D., Professor of Chemistry and the former Director of the Center for Biomedical Research at Oakland University. It is one of 4 biotechnology companies founded by Professor Callewaert.
Oxford Biomedical Research seeks to provide biomedical researchers with the best tools available for the analysis of Oxidative Stress and Chronic Inflammation – two of the most important risk factors that play key roles in the development of a wide range of human illness, including cancer, cardiovascular disease, diabetes and neurodegeneration.
Product range includes: proteins, peptides, antibodies, assay kits and related products. The products have been developed for researchers interested in:
- Eicosanoid Metobolism
- Oxidative Stress
- Signal Transduction
- Vascular Biology
- Xenobiotic Metabolism
Oxford Expression Technologies Ltd. has emerged from a collaboration between Oxford Brookes University and the Natural Environment Research Council. It provides products, services and consultancy to the global pharmaceutical and biotechnology industries from its base in Oxford, England, which has quickly become a world renowned centre of excellence for Baculovirus protein expression.
Oxford Expression Technologies flashBAC™ is a one step high throughput platform that enables fast and simultaneous production of multiple recombinant viruses suitable for small and large protein expression systems allowing scientists to produce proteins faster, more easily and cost-effectively.
The flashBAC™ baculovus protein expression system offers the following advantages:
- RAPID – one-step proceedure with no tedius selection stages. Amplified virus stock is produced in only 7 to 10 days
- FLEXIBLE – suitable for the production of single or multiple viruses, by manual or automated methods
- SIMPLE – no plaque or other tiresome, time consuming selection procedures
- EFFECTIVE – gentically optimised to deliver excellent protein yield and quality
Oxford Genetics was founded in 2011 by Dr Ryan Cawood with the aim to revolutionize DNA design, optimisation and assembly to enable molecular engineering to fulfil its promise in synthetic biology and medicine. Ryan is an experienced genetic engineer with extensive knowledge and practical insight working with bacterial, botanical and mammalian recombinant expression systems.
Oxford Genetics is a leading synthetic biology company focused on developing novel technologies to overcome the challenges associated with the discovery, development and production of biologics, gene therapies, cell therapies and vaccines.
Their proprietary genomic system enables the precise engineering of DNA, which in combination with our automated platforms, drive the rational design of complex biologics and their associated production processes.
ProSpec is an evolving biotech company providing highly purified proteins worldwide which serve the research community with cytokine-related products for cancer, apoptosis, development, endocrinology, immunology, neuroscience, proteases, and stem cell research.
Among the range of proteins are Interferons, Interleukins, Bone Morphogenic Proteins, Tumor Necrosis factors, Leptins, Stem Cell factors, Prolactins, Chemokines, Antibodies, Peptides, Enzymes, Viral Antigens, various growth factors such as: Platelet Derived, Epidermal, Insulin Like, Nerve, Connective Tissue, Vascular Endothelial, Fibroblast and many more.
ProSpec now have more than 6000 recombinant high quality proteins, peptides and antibodies available.
From a simple beginning in 1953, as a disposable towel/bib manufacturer, Crosstex has steadily grown to become one of the world’s leading infection prevention and control entities. Crosstex became a wholly owned subsidiary of Cantel Medical Corp. in August, 2005. On March 1, 2016, NAMSA’s Sterilization Products business was acquired by Crosstex Industrial.
Crosstex Industrial Sterilisation Products are known for their consistent performance. Their products are used by pharmaceutical and medical device manufacturers, contract sterilisers, laboratories and biotechnology companies.
Their products are used to monitor and assure the adequate sterilisation of products and instruments, distinguish processed from unprocessed goods, validate the effectiveness of the sterilisation process and to monitor every sterilisation load.
Product range includes:
- Chemical Process Indicators (CPI)
- Biological Indicators (BI)
- Self Contained Biological Indicators (SCBI)
- Custom Products – CPI’s and BI’s produced to an individual customer’s requirements
- QC Organisms/Growth Promotion
Microbiologics was founded in 1971 and is headquartered in St. Cloud, Minnesota. Originally named Environmental Protection Laboratories, they initially focused on providing laboratory testing services for detecting microbial contamination of water sources, the environment and food products. In 1976, Microbiologics began manufacturing and selling laboratory supplies including lyophilized (freeze-dried) microorganisms. Today, they provide QC microorganisms to every region of the world through an extensive distribution network.
Microbiologics is a leading producer of lyophilised microorganisms for quality control in microbiology laboratories world-wide. Specialising in clinical, pharmaceutical, cosmetic, industrial, food quality, environmental and educational markets, there are over 3,000 items in the product range.
Choose from more than 800 microorganisms from well known culture collections from around the world including ATCC®, NCIMB, NCTC and more.
|The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC. Microbiologics, Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures.|
|** Microbiologics® and Microbiologics® Licensed and Supply Program are registered trademarks of Microbiologics, Inc. St Cloud, MN, USA|